These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14365945)

  • 1. Observations on the experimental encephalitis produced with the use of gray matter phosphatide and vaccinelymph.
    KAWAI H
    Folia Psychiatr Neurol Jpn; 1954 Dec; 8(3):281-93. PubMed ID: 14365945
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on allergic encephalitis experimentally produced by the use of gray matter phosphatide and egg albumin.
    KAWAI H
    Folia Psychiatr Neurol Jpn; 1954 Dec; 8(3):265-80. PubMed ID: 14365944
    [No Abstract]   [Full Text] [Related]  

  • 3. Observations on allergic encephalitis experimentally produced by the use of gray matter phosphatide.
    SAWAMI H
    Folia Psychiatr Neurol Jpn; 1952 Sep; 6(2):138-54. PubMed ID: 13060420
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on experimental allergic encephalitis. II. Observation on allergic encephalitis experimentally produced by the use of white matter phosphatide conjugated with vaccine.
    TERAI H
    Folia Psychiatr Neurol Jpn; 1955 Jun; 9(1):20-33. PubMed ID: 13305668
    [No Abstract]   [Full Text] [Related]  

  • 5. PROGRESSIVE POLIODYSTROPHY. THE DEGENERATIONS OF CEREBRAL GRAY MATTER.
    DREIFUSS FE; NETSKY MG
    Am J Dis Child; 1964 Jun; 107():649-56. PubMed ID: 14133827
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on experimental allergic encephalitis. I. Observation on allergic encephalitis experimentally produced by the use of white matter phosphatide conjugated with bovine serum.
    TERAI H
    Folia Psychiatr Neurol Jpn; 1955 May; 8(4):371-91. PubMed ID: 13241636
    [No Abstract]   [Full Text] [Related]  

  • 7. A Simplified Approach to Encephalitis and Its Mimics: Key Clinical Decision Points in the Setting of Specific Imaging Abnormalities.
    McKnight CD; Kelly AM; Petrou M; Nidecker AE; Lorincz MT; Altaee DK; Gebarski SS; Foerster B
    Acad Radiol; 2017 Jun; 24(6):667-676. PubMed ID: 28258904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytotoxic damage of the gray substance during the course of an unclassified encephalitis].
    OSETOWSKA E; KRASNICKA Z; KOELICHEN A
    Neurol Neurochir Psychiatr Pol; 1962; 12():427-31. PubMed ID: 13940506
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the effect of monovalent chloride compounds on the nerve cells of the central gray matter of the cerebral cortex. (Preliminary report)].
    RUSCAKOVA D
    Biologia (Bratisl); 1961; 16():925-9. PubMed ID: 14495337
    [No Abstract]   [Full Text] [Related]  

  • 10. Further observations on the effects of ethanolamine phosphatide on plasma coagulation.
    POOLE JC; ROBINSON DS
    Q J Exp Physiol Cogn Med Sci; 1956 Jul; 41(3):295-300. PubMed ID: 13485345
    [No Abstract]   [Full Text] [Related]  

  • 11. Dynamic cortical gray matter volume changes after botulinum toxin in cervical dystonia.
    Delnooz CC; Pasman JW; van de Warrenburg BP
    Neurobiol Dis; 2015 Jan; 73():327-33. PubMed ID: 25447226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental bacterial endocarditis (endocarditis lenta; effects and significance of phosphatide)].
    MIKATA I; MURAKAMI ; NARITA
    Munch Med Wochenschr; 1956 Aug; 98(31):1032-4. PubMed ID: 13358676
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterotopic cerebral gray matter as an epileptogenic focus.
    LAYTON DD
    J Neuropathol Exp Neurol; 1962 Apr; 21():244-9. PubMed ID: 14463062
    [No Abstract]   [Full Text] [Related]  

  • 14. Diffuse traumatic degeneration of the cerebral gray matter.
    DENST J; RICHEY TW; NEUBUERGER KT
    J Neuropathol Exp Neurol; 1958 Jul; 17(3):450-60. PubMed ID: 13564256
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anatomo-clinical data on carbon monoxide coma followed by encephalitis, predominantly extrapyramidal; fatal evolution in q 24 days; alterations of pallidum and substantic nigra and cortical gray matter].
    ROGER H; POURSINES Y; ALLIEZ J
    Ann Med Psychol (Paris); 1952 Jun; 110(2 1):144-50. PubMed ID: 12986411
    [No Abstract]   [Full Text] [Related]  

  • 16. Widespread softening of the cerebral gray matter in infancy. Its probable etiology in a paranatal circulatory disorder.
    COURVILLE CB
    Bull Los Angel Neuro Soc; 1960 Jun; 25():72-88. PubMed ID: 13812423
    [No Abstract]   [Full Text] [Related]  

  • 17. Cortical gray matter lesions in acute encephalopathy with febrile convulsive status epilepticus.
    Sato A; Mizuguchi M; Mimaki M; Takahashi K; Jimi H; Oka A; Igarashi T
    Brain Dev; 2009 Sep; 31(8):622-4. PubMed ID: 18848752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case studies in cerebral anoxia. VI. Typical anoxic alterations in the cerebral gray matter after overdosage of barbiturates.
    COURVILLE CB
    Bull Los Angel Neuro Soc; 1955 Mar; 20(1):16-24. PubMed ID: 14364016
    [No Abstract]   [Full Text] [Related]  

  • 19. Case studies in cerebral anoxia. IV. Charac teristic changes in cerebral gray matter in anterior poliomyelitis.
    COURVILLE CB; BLOSSOM RA
    Bull Los Angel Neuro Soc; 1954 Sep; 19(3):151-9. PubMed ID: 13199451
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebral gray matter changes in persistent postural perceptual dizziness.
    Wurthmann S; Naegel S; Schulte Steinberg B; Theysohn N; Diener HC; Kleinschnitz C; Obermann M; Holle D
    J Psychosom Res; 2017 Dec; 103():95-101. PubMed ID: 29167054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.